Case Report

Prolonged Sinus Pauses with Hydromorphone in the Absence of Cardiac Conduction Disease

Authors: Brian S. Snarr, PhD, Christopher P. Rowley, MD, Stephanie V. Phan, PharmD, Anand Achanti, MD, Grady H. Hendrix, MD

Abstract

A 49-year-old male had open sigmoid colectomy with colorectal anastomosis for sigmoid diverticulitis. The patient was given patient-controlled analgesia (PCA) hydromorphone and subsequently developed bradycardia with prolonged sinus pauses up to 7.1 seconds. The pauses resolved shortly after the hydromorphone was discontinued. This is the first case report to our knowledge of reversible prolonged sinus pauses associated with the use of hydromorphone. Animal studies support a role for opioid signaling at the sinoatrial (SA) node. Hydromorphone is a potential cause of prolonged sinus pauses and should be taken into consideration when monitoring a patient on hydromorphone for pain control.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Talan DA, Bauernfeind RA, Ashley WW, et al. Twenty-four hour continuous ECG recordings in long-distance runners. Chest 1982;82:19–24.
 
2. Hocini M, Sanders P, Deisenhofer I, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation 2003;108:1172–1175.
 
3. Dilaudid®. Dilaudid-HP® injection [prescribing information]. Lake Forest, IL, Hospira, Inc., 2008.
 
4. Zosyn. Zosyn [prescribing information]. Philadelphia, PA, Wyeth Pharmaceuticals, Inc., 2009.
 
5. Chang AK, Bijur PE, Davitt M, et al. Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain. Ann Emerg Med 2009;54:561–567.
 
6. Deo SH, Barlow MA, Gonzalez L, et al. Cholinergic location of delta-opioid receptors in canine atria and SA node. Am J Physiol Heart Circ Physiol 2008;295:H829–H838.
 
7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.